Compare NKTX & RGCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NKTX | RGCO |
|---|---|---|
| Founded | 2015 | 1912 |
| Country | United States | United States |
| Employees | N/A | 106 |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 198.2M | 229.4M |
| IPO Year | 2020 | 2005 |
| Metric | NKTX | RGCO |
|---|---|---|
| Price | $2.66 | $22.02 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 1 |
| Target Price | $11.33 | ★ $22.70 |
| AVG Volume (30 Days) | ★ 589.3K | 13.6K |
| Earning Date | 05-11-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 3.93% |
| EPS Growth | ★ 11.88 | 11.21 |
| EPS | N/A | ★ 1.37 |
| Revenue | N/A | ★ $95,334,212.00 |
| Revenue This Year | N/A | $11.06 |
| Revenue Next Year | N/A | $2.89 |
| P/E Ratio | ★ N/A | $16.11 |
| Revenue Growth | N/A | ★ 12.63 |
| 52 Week Low | $1.70 | $20.55 |
| 52 Week High | $3.72 | $27.17 |
| Indicator | NKTX | RGCO |
|---|---|---|
| Relative Strength Index (RSI) | 60.57 | 45.78 |
| Support Level | $2.59 | $20.81 |
| Resistance Level | $2.81 | $22.80 |
| Average True Range (ATR) | 0.15 | 0.62 |
| MACD | 0.06 | 0.10 |
| Stochastic Oscillator | 98.37 | 50.00 |
Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK-cell expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.
RGC Resources Inc is involved in the business of distribution and sale of natural gas to residential, commercial, and industrial customers within its service territory in Roanoke, Virginia, and its surrounding localities. The company also provides certain non-regulated services. The company relies on multiple interstate pipelines to transport natural gas. The company operates in three segments: Gas Utility, which is the key revenue generator; Investment in Affiliates this segment reflects the income generated through the activities of the Company's investment in MVP and Southgate projects and Parent & Other including the unregulated activities of the Company as well as certain corporate eliminations.